Michael Burgess actually said...

"I also want to take a minute to applaud my friend from Oregon, Rep. Schrader, and Rep. Bilirakis, for working together on pursuing additional ways to promote more generic competition."

"It is important. I am glad we are able to come together in a bipartisan fashion to make this happen."

"Reauthorizing improved generic and biosimilar user fee programs will lead to timelier approvals and lower drug costs. It's that simple."

"We must remain vigilant in ensuring government does not get in the way of the very innovation that can keep us safe."